Back to Search Start Over

A rare point mutation in the Ras oncogene in hepatocellular carcinoma.

Authors :
Taketomi, Akinobu
Shirabe, Ken
Muto, Jun
Yoshiya, Shohei
Motomura, Takashi
Mano, Yohei
Ikegami, Tohru
Yoshizumi, Tomoharu
Sugio, Kenji
Maehara, Yoshihiko
Source :
Surgery Today. Mar2013, Vol. 43 Issue 3, p289-292. 4p.
Publication Year :
2013

Abstract

Purpose: The Ras gene is one of the oncogenes most frequently detected in human cancers, and codes for three proteins (K-, N-, and H-Ras). The aim of this study was to examine the mutations in codons 12, 13 and 61 of the three Ras genes in cases of human hepatocellular carcinoma (HCC). Methods: Paired samples of HCC and corresponding non-malignant liver tissue were collected from 61 patients who underwent hepatectomy. A dot-blot analysis was used to analyze the products of the polymerase chain reaction (PCR) amplification of codons 12, 13, and 61 of K-, N- and H-Ras for mutations. Results: Only one mutation (K-Ras codon 13; Gly to Asp) was detected among the 61 patients. Interestingly, this patient had a medical history of surgery for both gastric cancer and right lung cancer. No mutations were found in codons 12 and 61 of K-Ras or codons 12, 13 and 61 of the N-Ras and H-Ras genes in any of the HCCs or corresponding non-malignant tissues. Conclusions: These findings indicated that the activation of Ras proto-oncogenes by mutations in codons 12, 13, and 61 does not play a major role in hepatocellular carcinogenesis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09411291
Volume :
43
Issue :
3
Database :
Academic Search Index
Journal :
Surgery Today
Publication Type :
Academic Journal
Accession number :
85596997
Full Text :
https://doi.org/10.1007/s00595-012-0462-8